| CXSL2500405 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2.2) | New Drug Application | 2025-05-21 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
| CXSL2500336 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2.2) | New Drug Application | 2025-04-28 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
| CYSB2500073 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(3.3) | Supplementary Application | 2025-04-03 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| CYSB2500069 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2025-03-28 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
| CYSB2500048 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2025-02-27 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| CXSL2500153 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2.2) | New Drug Application | 2025-02-18 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
| CXSL2500161 | BC006单抗注射液 | bevacizumab | Injection | Biological Products(1) | New Drug Application | 2025-02-18 | | Baochuan Biological Medicine Technology (Shanghai) Co Ltd | | | view |
| CYSB2500037 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2025-02-07 | | QILU Pharmaceutical Co Ltd | | | view |
| CYSB2500023 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(3.3) | Supplementary Application | 2025-01-24 | | QILU Pharmaceutical Co Ltd | | | view |
| CYSB2500022 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(3.3) | Supplementary Application | 2025-01-24 | | QILU Pharmaceutical Co Ltd | | | view |
| CXSL2500042 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2.2) | New Drug Application | 2025-01-14 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
| CYSB2400336 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2025-01-01 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| CXSL2400911 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2.2) | New Drug Application | 2024-12-27 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
| CXSL2400870 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2.2) | New Drug Application | 2024-12-17 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
| CYSB2400313 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2024-12-05 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| CYSB2400308 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2024-11-27 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| CXSL2400488 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2.2) | New Drug Application | 2024-07-27 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
| CYSB2400183 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2024-07-18 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| JYSB2400153 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2024-07-16 | | Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG | | | view |
| CYSB2400153 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2024-06-14 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
